000 | 01691 a2200493 4500 | ||
---|---|---|---|
005 | 20250517172809.0 | ||
264 | 0 | _c20180806 | |
008 | 201808s 0 0 eng d | ||
022 | _a1365-2125 | ||
024 | 7 |
_a10.1111/bcp.13425 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBenoist, Guillemette Emma | |
245 | 0 | 0 |
_aDrug-drug interaction potential in men treated with enzalutamide: Mind the gap. _h[electronic resource] |
260 |
_bBritish journal of clinical pharmacology _cJan 2018 |
||
300 |
_a122-129 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aDatabases, Pharmaceutical _xstatistics & numerical data |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aDrug Monitoring _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNitriles |
650 | 0 | 4 |
_aPhenylthiohydantoin _xanalogs & derivatives |
650 | 0 | 4 | _aPolypharmacy |
650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTertiary Care Centers _xstatistics & numerical data |
700 | 1 | _avan Oort, Inge M | |
700 | 1 | _aSmeenk, Stella | |
700 | 1 | _aJavad, Adrian | |
700 | 1 | _aSomford, Diederik M | |
700 | 1 | _aBurger, David M | |
700 | 1 | _aMehra, Niven | |
700 | 1 | _avan Erp, Nielka P | |
773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 84 _gno. 1 _gp. 122-129 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.13425 _zAvailable from publisher's website |
999 |
_c27537008 _d27537008 |